Age: 49.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Hyperhidrosis, Hypersensitivity, Immunisation, Nasopharyngitis
Clinical narrative: Chills; sweats; cold; allergy symptoms; Booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 02Nov2021 12:45 (Lot number: F73527) at the age of 49 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "hypertension" (unspecified if ongoing); "mood disorder" (unspecified if ongoing); "depression" (unspecified if ongoing); "sleep apnea" (unspecified if ongoing); "mild asthma" (unspecified if ongoing); "seasonal allergies" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL; ATENOLOL; LAMOTRIGINE; WELLBUTRIN; D3. Vaccination history included: Bnt162b2 (Dose:1, Prev dose product= covid 19, Prev dose brand= pfizer, Prev dose brand unknown=false, Prev dose lot number= EM9809, Prev dose lot unknown=false, Prev dose administration date=09Feb2021,, Prev dose administration time=01:00 PM , Prev dose dose number=1, Prev dose vaccine location=left arm), administration date: 09Feb2021, when the patient was 48 years old, for COVID-19 immunization, reaction(s): "Tested positive for COVID19 on Saturday", "Tested positive for COVID19 on Saturday"; Bnt162b2 (Dose:2, Previous dose details, Prev dose product= covid 19, Prev dose brand= pfizer, Prev dose brand unknown=false, Prev dose lot number= EN6205, Prev dose lot unknown=false, Prev dose administration date=02Mar2021, Prev dose administration time=01:00 PM, Prev dose dose number=2, Prev dose vaccine location=left arm), administration date: 02Mar2021, when the patient was 48 years old, for COVID-19 immunization, reaction(s): "Tested positive for COVID19 on Saturday", "Tested positive for COVID19 on Saturday". The following information was reported: IMMUNISATION (non-serious) with onset 02Nov2021 12:45, outcome "unknown", described as "Booster"; CHILLS (non-serious) with onset 03Nov2021 05:00, outcome "recovering", described as "Chills"; HYPERHIDROSIS (non-serious) with onset 03Nov2021 05:00, outcome "recovering", described as "sweats"; NASOPHARYNGITIS (non-serious) with onset 03Nov2021 05:00, outcome "recovering", described as "cold"; HYPERSENSITIVITY (non-serious) with onset 03Nov2021 05:00, outcome "recovering", described as "allergy symptoms". The events "chills", "sweats", "cold" and "allergy symptoms" were evaluated at the emergency room visit. Therapeutic measures were not taken as a result of chills, hyperhidrosis, nasopharyngitis, hypersensitivity. Additional information: The patient had no Known allergies and no covid prior to vaccination. Developed symptoms on Wednesday AM after having vaccine on Tuesday afternoon. Chills, sweats, etc. Then cold and allergy symptoms. Tested positive for COVID19 on Saturday after vaccine and though he believed he can't get the virus as a direct result, he wanted to make aware in case of any cross contamination issues that may effect others.  No follow-up attempts are possible. No further information is expected.